SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-057708
Filing Date
2021-11-09
Accepted
2021-11-09 16:01:39
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150210-8k_augmedixinc.htm   iXBRL 8-K 33088
2 PRESS RELEASE DATED NOVEMBER 9, 2021 ANNOUNCING THIRD QUARTER 2021 FINANCIAL RES ea150210ex99-1_augmedixinc.htm EX-99.1 55377
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2975
  Complete submission text file 0001213900-21-057708.txt   277087

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE augx-20211109.xsd EX-101.SCH 3025
5 XBRL LABEL FILE augx-20211109_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE augx-20211109_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea150210-8k_augmedixinc_htm.xml XML 3716
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 211391940
SIC: 7389 Services-Business Services, NEC